Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from SoftOx Solutions AS ( (DE:6FV) ) is now available.
SoftOx Solutions AS has announced the issuance of 15 million shares as part of a financing agreement with Long State Investments Limited, aiming to secure necessary funding. The board decided to waive shareholders’ preferential rights to expedite the process, concluding that a subsequent offering would not be cost-effective.
More about SoftOx Solutions AS
SoftOx Solutions AS is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo, focusing on developing pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The company collaborates with leading Nordic research institutes for its research and development efforts.
YTD Price Performance: 614.29%
Average Trading Volume: 22,026,287
Current Market Cap: NOK235.2M
For detailed information about 6FV stock, go to TipRanks’ Stock Analysis page.